Position in ZTS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$106,743
+$62,077 QoQ
Shares Held
903
+154.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Derivatives in ZTS
reported options exposure · as of Mar 31, 2026CallValue
$106,389
CallShares
900
PutValue
$224,599
PutShares
1,900
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Capula Management Ltd holds $0 across 1 Drug Manufacturers - Specialty & Generic name.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | 930,160 | $0 |
All Filings in ZTS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $224,599 | 1,900 | Put | Defined | 2026-05-14 | |
| 2026-03-31 | $106,389 | 900 | Call | Defined | 2026-05-14 | |
| 2026-03-31 | $106,743 | 903 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $44,666 | 355 | Shares | Defined | 2026-02-13 | |
| 2025-12-31 | $75,492 | 600 | Call | Defined | 2026-02-13 | |
| 2025-12-31 | $100,656 | 800 | Put | Defined | 2026-02-13 | |
| 2023-03-31 | $299,092 | 1,797 | Shares | Defined | 2023-05-10 | |
| 2022-12-31 | $973,971 | 6,646 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $956,470 | 6,450 | Shares | Defined | 2022-11-14 | |
| 2021-06-30 | $242,268 | 1,300 | Shares | Defined | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||